CD34+ Hematopoietic Stem and Progenitor Cells From Different Tissue Sources For Cell Therapy
HemaCare. CD34+ Hematopoietic Stem and Progenitor Cells From Different Tissue Sources For Cell Therapy. May 2018: 1-4
Read MoreHemaCare. CD34+ Hematopoietic Stem and Progenitor Cells From Different Tissue Sources For Cell Therapy. May 2018: 1-4
Read MoreLacher, M. D., Bauer, G., Fury, B., Graeve, S., Fledderman, E. L., Petrie, T. D., Coleal-Bergum, D. P., Hackett, T., Perotti, N. H., Kong, Y. Y., Kwok, W. W., Wagner, J. P., Wiseman, C. L., Williams, W. V. SV-BR-1-GM, A Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses An Immune Signature And Directly Activates CD4+…
Read MoreHawkins B, Abazari A, Mathew A. Biopreservation Best Practices for Regenerative Medicine GMP Manufacturing & Focus on Optimized Biopreservation Media. Cell & Gene Therapy Insights – ISSN: 2059-7800. DOI: 10.18609/cgti.2017.035
Read MoreHawkins B, Abazari A, Mathew A. Biopreservation Best Practices for Regenerative Medicine GMP Manufacturing & Focus on Optimized Biopreservation Media. Cell & Gene Therapy Insights – ISSN: 2059-7800. DOI: 10.18609/cgti.2017.035
Read MoreFink J, Abazari A, Hawkins B, Albert M, O’Donnell K, Mathew A. Best Practices vs. Traditional Practices of Procedures and Technology for Preserving Viability and Functionality of T-Cells at Both -80 C and -190 C. Biopreservation and Biobanking Volume 15, Number 3, 2017. DOI:10.1089=bio.2017.29021.abstracts
Read MoreCryopreservation and Transport of Jurkat T Cells Using Current and Optimized Practices: The Impact of Temperature and Length of Storage
Read MoreNext Generation Technology Procedures and Products Facilitate Biopreservation Best Practices and Increased Viability for Cellular Therapy
Read More